New Delhi, Oct 26 (IANS) Diabetics can now look forward to a new therapy that combines an insulin pump with continuous glucose readings that will allow them to take necessary precautionary steps to check the disease.
US-based Medtronic Inc. has brought out the insulin pump, which has a glucose-meter that gives real time reading and helps the patient keep a track of the blood-sugar level.
'India is currently facing an epidemic in terms of diabetic cases,' said Medtronic India chief Adrian Gut.
'This kind of insulin pump is first of its kind we bring to India and we hope it checks the number of diabetic cases here,' Gut told IANS.
The $11.3 billion medical technology firm has opened 40-45 training centres on the usage of the pump and plans to double it by the end of this financial year.
'This will not be available to retail medical shops as this is a therapy which doctors will prescribe based on the patient's situation,' explained Gut.
The company has tied up with leading hospitals in the country such as the All India Institute of Medical Sciences (AIIMS), Apollo Hospitals, Escorts and Army Hospital to market the product and increase its awareness among potential consumers.
'This is going to be revolutionary in checking the increasing trend of diabetes in India, and it will also help us in understanding a patient's progress,' said S.K. Wangnoo, a senior consultant with Apollo Hospitals Delhi.
The therapy would cost Rs.275,000. A sensor that needs to be changed after every 72 hours would cost Rs.7,400.